Oncology: Servier collaborates to create innovative application for researchers
All the news from Servier Group
Servier certified Top Employer Europe 2022!
Servier presents its 2020/21 annual results, its R&D strategy and pipeline
Immuno-oncology: Servier and Aqemia cooperate on AI and quantum physics-driven drug discovery
Servier joins the Act4Nature International Initiative
Immuno-oncology: Servier and Pieris announce dosing of first patient in phase 1/2 trial
Neurodegenerative diseases: Servier enter into a new research collaboration
Servier and OSE Immunotherapeutics announce enrollment of first patient in Phase 2 Clinical Trial in Sjögren’s Syndrome
Neuroscience: new research partnership for Servier